Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-10-21

Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Minocycline in Angelman Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluated the efficacy and safety of minocycline for Angelman syndrome and has completed; no results are provided in the snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Minocycline (minocycline)

Snippet

Sponsor: Puerta de Hierro University Hospital | Conditions: Angelman Syndrome | Phase 2 | Status: COMPLETED